Literature DB >> 26431822

Gene therapy for age-related macular degeneration.

Robert E MacLaren1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26431822      PMCID： PMC5084873          DOI： 10.1016/S0140-6736(15)00346-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   202.731


× No keyword cloud information.
  12 in total

1.  Preclinical safety evaluation of subretinal AAV2.sFlt-1 in non-human primates.

Authors:  C-M Lai; M J Estcourt; R P Himbeck; S-Y Lee; I Yew-San Yeo; C Luu; B K Loh; M W Lee; A Barathi; J Villano; C-L Ang; R G van der Most; I J Constable; D Dismuke; R J Samulski; M A Degli-Esposti; E P Rakoczy
Journal:  Gene Ther       Date:  2011-11-10       Impact factor: 5.250

2.  Gene therapy with recombinant adeno-associated vectors for neovascular age-related macular degeneration: 1 year follow-up of a phase 1 randomised clinical trial.

Authors:  Elizabeth P Rakoczy; Chooi-May Lai; Aaron L Magno; Matthew E Wikstrom; Martyn A French; Cora M Pierce; Steven D Schwartz; Mark S Blumenkranz; Thomas W Chalberg; Mariapia A Degli-Esposti; Ian J Constable
Journal:  Lancet       Date:  2015-09-30       Impact factor: 79.321

3.  Adenoviral vector-delivered pigment epithelium-derived factor for neovascular age-related macular degeneration: results of a phase I clinical trial.

Authors:  Peter A Campochiaro; Quan Dong Nguyen; Syed Mahmood Shah; Michael L Klein; Eric Holz; Robert N Frank; David A Saperstein; Anurag Gupta; J Timothy Stout; Jennifer Macko; Robert DiBartolomeo; Lisa L Wei
Journal:  Hum Gene Ther       Date:  2006-02       Impact factor: 5.695

4.  Influence of promoter and WHV post-transcriptional regulatory element on AAV-mediated transgene expression in the rat brain.

Authors:  J C Paterna; T Moccetti; A Mura; J Feldon; H Büeler
Journal:  Gene Ther       Date:  2000-08       Impact factor: 5.250

5.  Inhibition of retinal neovascularisation by gene transfer of soluble VEGF receptor sFlt-1.

Authors:  J W B Bainbridge; A Mistry; M De Alwis; E Paleolog; A Baker; A J Thrasher; R R Ali
Journal:  Gene Ther       Date:  2002-03       Impact factor: 5.250

6.  Implantable MicroPump for Drug Delivery in Patients with Diabetic Macular Edema.

Authors:  Mark Humayun; Arturo Santos; Juan Carlos Altamirano; Ramiro Ribeiro; Roberto Gonzalez; Alejandro de la Rosa; Jason Shih; Changling Pang; Fukang Jiang; Philip Calvillo; John Huculak; Jenna Zimmerman; Sean Caffey
Journal:  Transl Vis Sci Technol       Date:  2014-12-01       Impact factor: 3.283

7.  Three-year follow-up after unilateral subretinal delivery of adeno-associated virus in patients with Leber congenital Amaurosis type 2.

Authors:  Francesco Testa; Albert M Maguire; Settimio Rossi; Eric A Pierce; Paolo Melillo; Kathleen Marshall; Sandro Banfi; Enrico M Surace; Junwei Sun; Carmela Acerra; J Fraser Wright; Jennifer Wellman; Katherine A High; Alberto Auricchio; Jean Bennett; Francesca Simonelli
Journal:  Ophthalmology       Date:  2013-03-06       Impact factor: 12.079

Review 8.  Causes of vision loss worldwide, 1990-2010: a systematic analysis.

Authors:  Rupert R A Bourne; Gretchen A Stevens; Richard A White; Jennifer L Smith; Seth R Flaxman; Holly Price; Jost B Jonas; Jill Keeffe; Janet Leasher; Kovin Naidoo; Konrad Pesudovs; Serge Resnikoff; Hugh R Taylor
Journal:  Lancet Glob Health       Date:  2013-11-11       Impact factor: 26.763

9.  Risk of geographic atrophy in the comparison of age-related macular degeneration treatments trials.

Authors:  Juan E Grunwald; Ebenezer Daniel; Jiayan Huang; Gui-Shuang Ying; Maureen G Maguire; Cynthia A Toth; Glenn J Jaffe; Stuart L Fine; Barbara Blodi; Michael L Klein; Alison A Martin; Stephanie A Hagstrom; Daniel F Martin
Journal:  Ophthalmology       Date:  2013-09-29       Impact factor: 12.079

Review 10.  Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA).

Authors:  Ursula Schmidt-Erfurth; Victor Chong; Anat Loewenstein; Michael Larsen; Eric Souied; Reinier Schlingemann; Bora Eldem; Jordi Monés; Gisbert Richard; Francesco Bandello
Journal:  Br J Ophthalmol       Date:  2014-09       Impact factor: 4.638
View more
  1 in total

1.  Technique of retinal gene therapy: delivery of viral vector into the subretinal space.

Authors:  K Xue; M Groppe; A P Salvetti; R E MacLaren
Journal:  Eye (Lond)       Date:  2017-08-18       Impact factor: 3.775
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.